Abiraterone Acetate in Combination With Tildrakizumab

Condition:   Metastatic Castration Resistant Prostate Cancer Interventions:   Drug: Abiraterone Acetate;   Drug: Tildrakizumab Sponsors:   Institute of Cancer Research, United Kingdom;   Sun Pharma Global FZE Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials